Literature DB >> 21350939

Tissue inhibitor of metalloproteinase-1 promotes NIH3T3 fibroblast proliferation by activating p-Akt and cell cycle progression.

Yang Lu1, Shuxin Liu, Shujia Zhang, Guangyan Cai, Hongwei Jiang, Huabin Su, Xiaofan Li, Quan Hong, Xueguang Zhang, Xiangmei Chen.   

Abstract

Tissue inhibitor of metalloproteinase-1 (TIMP-1) plays various roles in cell growth in different cell types. However, few studies have focused on TIMP-1's effect on fibroblast cells. In this study, we investigated the effects of TIMP-1 overexpression on NIH3T3 fibroblast proliferation and potential transduction signaling pathways involved. Overexpression of TIMP-1, by transfection of the pLenti6/V5-DESTTIMP-1 plasmid, significantly promoted NIH3T3 proliferation as determined by the BrdU array. Neither 5 nor 15 nM GM6001 (matrix metalloproteinase system inhibitor) affected NIH3T3 proliferation, but 45 nM GM6001 inhibited proliferation. TIMP-1 overexpression activated the p-Akt pathway, but not the p-ERK or p-p38 pathway. In TIMP-1-transfected cells, cyclinD1 was upregulated and p21CIP1 and p27(KIP1) were downregulated, which promoted cell entry into the S and G2/M phases. The PI3-K inhibitor LY294002 abolished the TIMP-1-induced effects. Overexpression of intracellular TIMP-1 stimulated NIH3T3 fibroblast proliferation in a matrix metalloproteinase (MMP)-independent manner by activating the p-Akt pathway and related cell cycle progression.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21350939      PMCID: PMC3932703          DOI: 10.1007/s10059-011-0023-9

Source DB:  PubMed          Journal:  Mol Cells        ISSN: 1016-8478            Impact factor:   5.034


  33 in total

1.  Tissue inhibitor of metalloproteinases-1 attenuates spontaneous liver fibrosis resolution in the transgenic mouse.

Authors:  Hitoshi Yoshiji; Shigeki Kuriyama; Junichi Yoshii; Yasuhide Ikenaka; Ryuichi Noguchi; Toshiya Nakatani; Hirohisa Tsujinoue; Koji Yanase; Tadashi Namisaki; Hiroo Imazu; Hiroshi Fukui
Journal:  Hepatology       Date:  2002-10       Impact factor: 17.425

2.  Tissue inhibitor of metalloproteinase-1 prevents cytokine-mediated dysfunction and cytotoxicity in pancreatic islets and beta-cells.

Authors:  X Han; Y Sun; S Scott; D Bleich
Journal:  Diabetes       Date:  2001-05       Impact factor: 9.461

3.  Tissue inhibitor of metalloproteinase 1 activates normal human granulocytes, protects them from apoptosis, and blocks their transmigration during inflammation.

Authors:  Milan Chromek; Kjell Tullus; Joachim Lundahl; Annelie Brauner
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

4.  Differential growth regulation in human melanoma cell lines by TIMP-1 and TIMP-2.

Authors:  T Hoashi; T Kadono; K Kikuchi; T Etoh; K Tamaki
Journal:  Biochem Biophys Res Commun       Date:  2001-10-26       Impact factor: 3.575

5.  Angiotensin II mediates LDL-induced superoxide generation in mesangial cells.

Authors:  So Yeon Park; Chi Young Song; Bong Cho Kim; Hye Kyoung Hong; Hyun Soon Lee
Journal:  Am J Physiol Renal Physiol       Date:  2003-07-01

6.  Both tissue inhibitors of metalloproteinases-1 (TIMP-1) and TIMP-2 activate Ras but through different pathways.

Authors:  Ting Wang; Kyoko Yamashita; Kazushi Iwata; Taro Hayakawa
Journal:  Biochem Biophys Res Commun       Date:  2002-08-09       Impact factor: 3.575

7.  Inhibition of apoptosis in rat mesangial cells by tissue inhibitor of metalloproteinase-1.

Authors:  Hongli Lin; Xiangmei Chen; Jianzhong Wang; Zhiheng Yu
Journal:  Kidney Int       Date:  2002-07       Impact factor: 10.612

8.  Tissue inhibitor of metalloproteinases-1 signalling pathway leading to erythroid cell survival.

Authors:  Elise Lambert; Cédric Boudot; Zahra Kadri; Mahdhia Soula-Rothhut; Marie-Line Sowa; Patrick Mayeux; William Hornebeck; Bernard Haye; Emmanuelle Petitfrere
Journal:  Biochem J       Date:  2003-06-15       Impact factor: 3.857

9.  Tissue inhibitor of metalloproteinase-1 protects human breast epithelial cells against intrinsic apoptotic cell death via the focal adhesion kinase/phosphatidylinositol 3-kinase and MAPK signaling pathway.

Authors:  Xu-Wen Liu; M Margarida Bernardo; Rafael Fridman; Hyeong-Reh Choi Kim
Journal:  J Biol Chem       Date:  2003-08-05       Impact factor: 5.157

10.  Tissue inhibitor of metalloproteinase-1 stimulates proliferation of human cancer cells by inhibiting a metalloproteinase.

Authors:  J F Porter; S Shen; D T Denhardt
Journal:  Br J Cancer       Date:  2004-01-26       Impact factor: 7.640

View more
  20 in total

Review 1.  Cytokine functions of TIMP-1.

Authors:  Christian Ries
Journal:  Cell Mol Life Sci       Date:  2013-08-28       Impact factor: 9.261

2.  Tissue inhibitor of metalloproteinases-1 induces a pro-tumourigenic increase of miR-210 in lung adenocarcinoma cells and their exosomes.

Authors:  H Cui; B Seubert; E Stahl; H Dietz; U Reuning; L Moreno-Leon; M Ilie; P Hofman; H Nagase; B Mari; A Krüger
Journal:  Oncogene       Date:  2014-09-29       Impact factor: 9.867

3.  Stat3 Controls Tubulointerstitial Communication during CKD.

Authors:  Frank Bienaimé; Mordi Muorah; Lucie Yammine; Martine Burtin; Clément Nguyen; Willian Baron; Serge Garbay; Amandine Viau; Mélanie Broueilh; Thomas Blanc; Dorien Peters; Valeria Poli; Dany Anglicheau; Gérard Friedlander; Marco Pontoglio; Morgan Gallazzini; Fabiola Terzi
Journal:  J Am Soc Nephrol       Date:  2016-05-06       Impact factor: 10.121

Review 4.  Targeting matrix metalloproteinases in heart disease: lessons from endogenous inhibitors.

Authors:  Francis G Spinale; Francisco Villarreal
Journal:  Biochem Pharmacol       Date:  2014-04-26       Impact factor: 5.858

Review 5.  Progression of chronic kidney disease: too much cellular talk causes damage.

Authors:  Leslie Gewin; Roy Zent; Ambra Pozzi
Journal:  Kidney Int       Date:  2016-10-20       Impact factor: 10.612

Review 6.  Matrix metalloproteinases in kidney homeostasis and diseases.

Authors:  Roderick J Tan; Youhua Liu
Journal:  Am J Physiol Renal Physiol       Date:  2012-04-04

Review 7.  Extracellular Vesicles in Facial Aesthetics: A Review.

Authors:  Li Ting Kee; Chiew Yong Ng; Maimonah Eissa Al-Masawa; Jhi Biau Foo; Chee Wun How; Min Hwei Ng; Jia Xian Law
Journal:  Int J Mol Sci       Date:  2022-06-16       Impact factor: 6.208

8.  Targeted Injection of a Truncated Form of Tissue Inhibitor of Metalloproteinase 3 Alters Post-Myocardial Infarction Remodeling.

Authors:  David C Lobb; Heather Doviak; Gregory L Brower; Eva Romito; Jason W O'Neill; Stephen Smith; James A Shuman; Parker D Freels; Kia N Zellars; Lisa A Freeburg; Aarif Y Khakoo; TaeWeon Lee; Francis G Spinale
Journal:  J Pharmacol Exp Ther       Date:  2020-09-21       Impact factor: 4.030

9.  Chronic exposure of interleukin-13 suppress the induction of matrix metalloproteinase-1 by tumour necrosis factor α in normal and scleroderma dermal fibroblasts through protein kinase B/Akt.

Authors:  M L Brown Lobbins; B R Shivakumar; A E Postlethwaite; K A Hasty
Journal:  Clin Exp Immunol       Date:  2017-10-02       Impact factor: 4.330

10.  Exosomes of adult human fibroblasts cultured on 3D silk fibroin nonwovens intensely stimulate neoangiogenesis.

Authors:  Peng Hu; Anna Chiarini; Jun Wu; Giuliano Freddi; Kaiyu Nie; Ubaldo Armato; Ilaria Dal Prà
Journal:  Burns Trauma       Date:  2021-05-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.